Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. Jan 15, 2016; 8(1): 128-135
Published online Jan 15, 2016. doi: 10.4251/wjgo.v8.i1.128
Published online Jan 15, 2016. doi: 10.4251/wjgo.v8.i1.128
Table 3 RAS and BRAF status and carcinoembryonic antigen levels
BRAF | BRAF | P | RAS | RAS | P | |||||||
All | MT | WT | MT | WT | ||||||||
n | % | n | % | n | % | n | % | n | % | |||
< 5 ng/mL | 60 | 34 | 4 | 7 | 56 | 93 | 1.00 | 37 | 62 | 23 | 38 | 0.037 |
≥ 5 ng/mL | 114 | 66 | 7 | 6 | 107 | 94 | 64 | 56 | 50 | 44 |
- Citation: Cho M, Akiba C, Lau C, Smith D, Telatar M, Afkhami M, Sentovich S, Melstrom K, Fakih M. Impact of RAS and BRAF mutations on carcinoembryonic antigen production and pattern of colorectal metastases. World J Gastrointest Oncol 2016; 8(1): 128-135
- URL: https://www.wjgnet.com/1948-5204/full/v8/i1/128.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i1.128